Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
84.00
+6.00 (7.69%)
At close: Mar 3, 2025
60.00%
Market Cap 306.76B
Revenue (ttm) 296.39B
Net Income (ttm) 50.25B
Shares Out 3.65B
EPS (ttm) 13.80
PE Ratio 6.09
Forward PE n/a
Dividend 7.60 (9.74%)
Ex-Dividend Date Feb 27, 2025
Volume 120,000
Average Volume 6,150
Open n/a
Previous Close 78.00
Day's Range 84.00 - 84.00
52-Week Range 52.50 - 84.00
Beta -0.14
RSI 100.00
Earnings Date Feb 7, 2025

About UGSE:QCIL

Quality Chemical Industries Limited, a pharmaceutical manufacturing company, produces treatments for HIV/AIDS, Malaria, Hepatitis, and other products in Uganda. It offers antibacterials, anti-hypertensives, vasodilators, anti-emetics, antibiotics, and antidiabetics products; and Lamivudine/Tenofovir Disoproxil Fumarate, Dolutegravir, Efavirenz, and Zidovudine tablets for the treatment of HIV infection. The company also offers Lumartem/Lumet tablets for the treatment of malaria; Texavir and Zentair for the treatment of Hepatitis B; and Isoniazid... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In 2023, UGSE:QCIL's revenue was 265.34 billion, an increase of 19.81% compared to the previous year's 221.47 billion. Earnings were 31.76 billion, an increase of 67.28%.

Financial Statements

News

There is no news available yet.